Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$2.36 - $3.35 $82,600 - $117,250
-35,000 Reduced 36.05%
62,096 $157,000
Q4 2022

Feb 07, 2023

SELL
$2.58 - $4.68 $25,800 - $46,800
-10,000 Reduced 9.34%
97,096 $261,000
Q3 2022

Nov 04, 2022

BUY
$2.7 - $4.3 $162,000 - $258,000
60,000 Added 127.4%
107,096 $295,000
Q1 2022

May 11, 2022

SELL
$4.88 - $8.56 $292,800 - $513,600
-60,000 Reduced 56.02%
47,096 $366,000
Q4 2021

Feb 11, 2022

SELL
$7.03 - $13.03 $281,200 - $521,200
-40,000 Reduced 27.19%
107,096 $753,000
Q2 2021

Aug 16, 2021

BUY
$13.68 - $22.34 $2.01 Million - $3.29 Million
147,096 New
147,096 $2.66 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $874M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.